Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Leupeptin . hemisulfate
45
CHF
CHF 45.00
In stock
AG-CP3-7000-M0055 mgCHF 45.00
AG-CP3-7000-M02525 mgCHF 125.00
AG-CP3-7000-M100100 mgCHF 370.00
Product Details | |
---|---|
Synonyms | Acetyl-L-leucyl-L-leucyl-L-argininal . hemisulfate |
Product Type | Chemical |
Properties | |
Formula |
C20H38N6O4 . 0.5 H2SO4 |
MW | 426.6 . 49.0 |
Sequence |
Ac-Leu-Leu-Arginal |
Merck Index | 14: 5456 |
CAS | 103476-89-7 |
Source/Host Chemicals | Synthetic. |
Purity Chemicals | ≥97% (HPLC) |
Appearance | White to off-white powder. |
Solubility | Soluble in ethanol, methanol or water. |
Other Product Data |
Leupeptin gives multiple peaks on HPLC due to equilibria among three forms in solution. Purity determined using three main peaks. Majority of contaminating peptide is racemized leupeptin. |
InChi Key | CIPMKIHUGVGQTG-VFFZMTJFSA-N |
Smiles | OS(O)(=O)=O.[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O.[H]C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(C)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light and moisture. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent, competitive and reversible cysteine, serine and threonine protease inhibitor. Inhibits calpain, kallikrein, trypsin, plasmin, papain and cathepsin B.
- Does not inhibit pepsin, elastase, renin, cathepsins A and D, thrombin or α-chymotrypsin.
- Used to protect against hearing loss caused by acoustic overstimulation or the ototoxic antibiotic gentamicin.
- Shown to inhibit activation-induced programmed cell death.
- Antioxidant and anti-inflammatory agent.
- Widely used as a protein purification tool to prevent proteases present in tissue samples from degrading the protein of interest.
- Molecular docking and molecular dynamics simulation of leupeptin with the transmembrane serine protease TMPRSS2, show strong interactions with the key amino acids Ser186, His41 and Asp180 of catalytic triad present in the active site of TMPRSS2. This interaction causes the inhibition of the function of TMPRSS2, which is essential for SARS-CoV-2 viral entry and infection. As an inhibitor of TMPRSS2 this agent could be repurposed for treatment of COVID-19.
Product References
- Leupeptins, new protease inhibitors from actinomycetes: T. Aoyagi, et al.; J. Antibiot. (Tokyo) 22, 283 (1969)
- Biological activities of leupeptins: T. Aoyagi; J. Antibiot. (Tokyo) 22, 558 (1969)
- Mechanism of association of a specific aldehyde inhibitor, leupeptin, with bovine trypsin: H. Kuramochi, et al.; J. Biochem. 86, 1403 (1979)
- The slow, tight-binding inhibition of cathepsin B by leupeptin. A hysteretic effect: A. Baici, et al.; Eur. J. Biochem. 129, 33 (1982)
- Leupeptin, a thiol proteinase inhibitor, causes a selective impairment of spatial maze performance in rats: U. Staubli, et al.; Behav. Neural. Biol. 40, 58 (1984)
- Leupeptin selectively inhibits human platelet responses induced by thrombin and trypsin; a role for proteolytic activation of phospholipase C: M. Ruggiero & E.G. Lapetina; BBRC 131, 1198 (1985)
- Protease-inhibitory activities of leupeptin analogues: T. Saino, et al.; J. Antibiot. (Tokyo) 41, 220 (1988)
- New leupeptin analogues: synthesis and inhibition data: R.M. McConnell, et al.; J. Med. Chem. 33, 86 (1990)
- Developing selective inhibitors of calpain: K.K. Wang, et al.; TIPS 11, 139 (1990)
- Cell-penetrating inhibitors of calpain: S. Mehdi, et al.; TIBS 16, 150 (1991)
- Inhibition studies of some serine and thiol proteinases by new leupeptin analogues: R.M. McConnell, et al.; J. Med. Chem. 36, 1084 (1993)
- Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors: A. Sarin, et al.; J. Immunol. 153, 862 (1994)
- Inhibition of mu and delta opioid receptor ligand binding by the peptide aldehyde protease inhibitor, leupeptin: K.H. Christoffers, et al.; Regul. Pept. 105, 9 (2002)
- In vitro antioxidant properties of calpain inhibitors: leupeptin and calpain inhibitor-1: C. Perrin, et al.; Cell. Mol. Biol. (Noisy-le-grand) 48, OL267 (2002)
- Inhibitors of cathepsin B: F. Frlan & S. Gobec; Curr. Med. Chem. 13, 2309 (2006)
- Leupeptin, a calpain inhibitor, protects inner ear hair cells from aminoglycoside ototoxicity: J. Momiyama, et al.; Tohoku J. Exp. Med. 209, 89 (2006)
- Leupeptin reduces impulse noise induced hearing loss: H. Gavriel, et al.; J. Occup. Med. Toxicol. 6, 38 (2011)
- Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations: J. Ramakrishnan, et al.; Appl. Biochem. Biotech. (epub ahead of print) (2021)